However, the clinical utility of plasma NfL is uncertain as recent evidence suggests that it adds marginal diagnostic value when used with other clinical assessments [38] and has poor diagnostic accuracy for AD [39]. This evidence concerns the gene NEFL and Alzheimer disease.